首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3465篇
  免费   283篇
  国内免费   3篇
  2023年   13篇
  2021年   36篇
  2020年   31篇
  2019年   51篇
  2018年   52篇
  2017年   40篇
  2016年   67篇
  2015年   105篇
  2014年   167篇
  2013年   167篇
  2012年   219篇
  2011年   207篇
  2010年   161篇
  2009年   148篇
  2008年   215篇
  2007年   228篇
  2006年   209篇
  2005年   218篇
  2004年   191篇
  2003年   167篇
  2002年   190篇
  2001年   58篇
  2000年   42篇
  1999年   42篇
  1998年   49篇
  1997年   34篇
  1996年   34篇
  1995年   41篇
  1994年   30篇
  1993年   35篇
  1992年   27篇
  1991年   30篇
  1990年   28篇
  1989年   24篇
  1988年   28篇
  1987年   19篇
  1986年   15篇
  1985年   34篇
  1984年   27篇
  1983年   20篇
  1982年   25篇
  1981年   17篇
  1980年   26篇
  1979年   11篇
  1978年   14篇
  1977年   13篇
  1976年   13篇
  1974年   14篇
  1973年   11篇
  1969年   10篇
排序方式: 共有3751条查询结果,搜索用时 296 毫秒
991.
992.
Caspases play a central role in apoptosis, but their activity is under the control of caspase-inhibiting proteins. A characteristic of caspase-inhibiting proteins is direct caspase binding. It is yet unknown how the localization of caspase-inhibiting proteins is regulated and whether there are upstream signals controlling their function. Here we report that the function of ARC is regulated by protein kinase CK2. ARC at threonine 149 is phosphorylated by CK2. This phosphorylation targets ARC to mitochondria. ARC is able to bind to caspase-8 only when it is localized to mitochondria but not to the cytoplasm. Our results reveal a molecular mechanism by which a caspase-inhibiting protein requires phosphorylation in order to prevent apoptosis.  相似文献   
993.
Aha,another regulator for hsp90 chaperones   总被引:2,自引:0,他引:2  
Mayer MP  Nikolay R  Bukau B 《Molecular cell》2002,10(6):1255-1256
A large number of key regulators controlling homeostasis and cell fate are chaperoned by the Hsp90 folding machine. In this issue of Molecular Cell, report the discovery of a new stress-regulated cochaperone, Aha1, which accelerates the dynamics of this machine.  相似文献   
994.
Grb2 is a key mediator of helicobacter pylori CagA protein activities   总被引:11,自引:0,他引:11  
CagA delivered from Helicobacter pylori into gastric epithelial cells undergoes tyrosine phosphorylation and induces host cell morphological changes. Here we show that CagA can interact with Grb2 both in vitro and in vivo, which results in the activation of the Ras/MEK/ERK pathway and leads to cell scattering as well as proliferation. Importantly, this ability of CagA is independent from the tyrosine phosphorylation, which occurs within the five repeated EPIYA sequences (PY region) of CagA. However, the PY region appears to be indispensable for the Grb2 binding and induction of the cellular responses. Thus, intracellular CagA via its binding to Grb2 may act as a transducer for stimulating growth factor-like downstream signals which lead to cell morphological changes and proliferation, the causes of H. pylori-induced gastric hyperplasia.  相似文献   
995.
Polyglycerol represents the first hyperbranched polymer that can be prepared in a controlled synthesis. It is characterized by the combination of a stable, biocompatible polyether scaffold, high-end group functionality and a compact, well-defined dendrimer-like architecture. These characteristics can be used to generate new materials properties and for biomedical applications to molecularly amplify or multiply effects or to create extremely high local concentrations of drugs, molecular labels, or probe moieties. Therefore, dendritic polyglycerols are expected to lead to new strategies for 'molecular medicine'. In this brief summary, the current state of the art in polyglycerol research is given, focusing on applications in life sciences.  相似文献   
996.
Using high temporally and spatially resolved confocal laser scanning microscopy, we have recently demonstrated the existence of elementary Ca(2+) release events (ECRE) in chemically and mechanically skinned fibres from adult mammalian skeletal muscle. Here, we present a first approach to the analysis of mammalian ECRE with a spatio-temporal mathematical model of Ca(2+) ion distribution in skinned muscle fibre preparations. The differential equations for the main processes, including sarcoplasmic reticulum Ca(2+) handling, are solved in a 2-D cylindrical geometry by the method of explicit finite differences. By calculating the various spatio-temporal ion concentrations as well as the theoretical fluorescence signals for confocal microscopy, corrected for the point spread function, the model output can be directly correlated with the experimental data. Thus, the basic features of mammalian ECRE were successfully reproduced with our model. In particular, under our model assumptions a considerable depletion of luminal free calcium is predicted even for short spark-like ECRE. For a full understanding of the molecular and sub-cellular events responsible for EC coupling it is vitally important to combine the experimental and modelling approaches to elucidate the contribution of mammalian ECRE to the global Ca(2+) release and its alteration under various physiological and also pathophysiological conditions.  相似文献   
997.
In eukaryotic cells, secretion is achieved by vesicular transport. Fusion of such vesicles with the correct target compartment relies on SNARE proteins on both vesicle (v-SNARE) and the target membranes (t-SNARE). At present it is not clear how v-SNAREs are incorporated into transport vesicles. Here, we show that binding of ADP-ribosylation factor (ARF)-GTPase-activating protein (GAP) to ER-Golgi v-SNAREs is an essential step for recruitment of Arf1p and coatomer, proteins that together form the COPI coat. ARF-GAP acts catalytically to recruit COPI components. Inclusion of v-SNAREs into COPI vesicles could be mediated by direct interaction with the coat. The mechanisms by which v-SNAREs interact with COPI and COPII coat proteins seem to be different and may play a key role in determining specificity in vesicle budding.  相似文献   
998.
A second gene for peroxisomal HMG-CoA reductase? A genomic reassessment   总被引:1,自引:0,他引:1  
HMG-CoA reductase (HMGCR) catalyzes the conversion of HMG-CoA to mevalonate, the rate-limiting step of eukaryotic isoprenoid biosynthesis, and is the main target of cholesterol-lowering drugs. The classical form of the enzyme is a transmembrane-protein anchored to the endoplasmic reticulum. However, during the last years several lines of evidence pointed to the existence of a second isoform of HMGCR localized in peroxisomes, where mevalonate is converted further to farnesyl diphosphate. This finding is relevant for our understanding of the complex regulation and compartmentalization of the cholesterogenic pathway. Here we review experimental evidence suggesting that the peroxisomal activity might be due to a second HMGCR gene in mammals. We then present a comprehensive analysis of completely sequenced eukaryotic genomes, as well as the human and mouse genome drafts. Our results provide evidence for a large number of independent duplications of HMGCR in all eukaryotic kingdoms, but not for a second gene in mammals. We conclude that the peroxisomal HMGCR activity in mammals is due to alternative targeting of the ER enzyme to peroxisomes by an as yet uncharacterized mechanism.  相似文献   
999.
Bivalent peptidic thrombin inhibitors consisting of an N-terminal d-cyclohexylalanine-Pro-N(alpha)(Me)Arg active-site fragment, a flexible polyglycine linker, and a C-terminal hirugen-like segment directed towards the fibrinogen recognition exosite inhibit thrombin with K(i) values in the picomolar range, remaining stable in buffered solution at pH 7.8 for at least 15 hours. In order to investigate the structural basis of this increased stability, the most potent of these inhibitors, I-11 (K(i)=37pM), containing an N(alpha)(Me)Arg-Thr bond, was crystallized in complex with human alpha-thrombin. X-ray data were collected to 1.8A resolution and the crystal structure of this complex was determined. The Fourier map displays clear electron density for the N-terminal fragment and for the exosite binding segment. It indicates, however, that in agreement with Edman sequencing, the peptide had been cleaved in the crystal, presumably due to the long incubation time of 14 days needed for crystallization and data collection. The N(alpha)(Me) group is directed toward the carbonyl oxygen atom of Ser214, pushing the Ser195 O(gamma) atom out of its normal site. This structure suggests that upon thrombin binding, the scissile peptide bond of the intact peptide and the Ser195 O(gamma) are separated from each other, impairing the nucleophilic attack of the Ser195 O(gamma) toward the N(alpha)(Me)Arg carbonyl group. In the time-scale of two weeks, however, cleavage geometries favoured by the crystal allow catalysis at a slow rate.  相似文献   
1000.
Enzymatic misrepair of ionizing-radiation-induced DNA damage can produce large-scale rearrangements of the genome, such as translocations and dicentrics. These and other chromosome exchange aberrations can cause major phenotypic alterations, including cell death, mutation and neoplasia. Exchange formation requires that two (or more) genomic loci come together spatially. Consequently, the surprisingly rich aberration spectra uncovered by recently developed techniques, when combined with biophysically based computer modeling, help characterize large-scale chromatin architecture in the interphase nucleus. Most results are consistent with a picture whereby chromosomes are mainly confined to territories, chromatin motion is limited, and interchromosomal interactions involve mainly territory surfaces. Aberration spectra and modeling also help characterize DNA repair/misrepair mechanisms. Quantitative results for mammalian cells are best described by a breakage-and-reunion model, suggesting that the dominant recombinational mechanism during the G(0)/G(1) phase of the cell cycle is non-homologous end-joining of radiogenic DNA double strand breaks. In turn, better mechanistic and quantitative understanding of aberration formation gives new insights into health-related applications.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号